Ayala Pharmaceuticals' Corporate Minority Round

Ayala Pharmaceuticals raised a round of funding on December 24, 2018. Investors include Novartis.

Ayala Pharmaceuticals is a precision oncology company developing targeted therapies for rare cancers that are clinically underserved.…

Articles about Ayala Pharmaceuticals' Corporate Minority Round: